Nanotechnology Environmental Health and Safety

Nanotechnology Environmental Health and Safety tackles - in depth and in breadth - the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). The chapters are authored by leaders in their respective fields, providing thorough analysis of their research areas. The diverse spectrum of topics include nanotechnology EHS issues, financial implications, foreseeable risks including exposure, dosage and hazards, and the implications of occupational hygiene precautions and consumer protections. The book includes real-world case studies, wherever practical, to illustrate specific issues and scenarios encountered by stakeholders positioned on the front-lines of nanotechnology-enabled industries. These case studies will appeal to, and resonate with, laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers. Reviews toxicological studies and industrial initiatives, supported by numerous case studies Covers new generation of nanoparticles and significantly expands on existing material from second edition Only edited volume to collect research on the regulatory and risk implications of a wide array of industrial, environmental and consumer nanomaterials

This book tackles the debate over nanotechnology's environmental health and safety (EHS) by thoroughly explaining EHS issues, financial implications, foreseeable risks (i.e. exposure, dose, hazards of nanomaterials), and the implications of occupational hygiene precautions and consumer protections. Real-world case studies are included, e.g. the discussion of a leading chemical company's unusual pairing with the USA's largest environmental NGO, and an innovative program designed for small- to mid-sized businesses, which became a model approach for proactive nanotechnology EHS risk management. Considers the potential of nanotechnology from multiple perspectives (NGO, insurance industry, small business, etc) Provides guidance and advice for appropriate, proactive risk management strategies Reviews toxicological studies and industrial initiatives, documented with actual case studies Of significant interest to CEOs/CTOs of technology companies (SMEs), Health and Safety officers of technology companies (SMEs), Government officials (HSE), Toxicology experts, and venture capitalists